2 hasil untuk "Mathijs P. Hendriks"
Menampilkan 1–2 · 0,58 detik · RSS
-
Artikel Jurnal Teks lengkap
Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol
Chemoradiotherapy with cisplatin in a triweekly regimen of 100 mg/m2 body surface area, is used to treat locally advanced head and neck squamous cell carcinoma (HNSCC) with curative intent. Cisplatin dose limiting toxicity (CDLT) occurs often and impedes obtaining the planned cumulative cisplatin…
-
Artikel Jurnal Teks lengkap
Patients’ and relatives’ perspectives on the quality of end-of-Life care in advanced cancer: From the final months to bereavement
Background: End-of-life care affects both patients with advanced cancer and their relatives but is often assessed from only one perspective, namely that of bereaved relatives. This study aimed to gain insight into the quality of care as experienced by patients with advanced cancer and their…